Skip to main content
Clinical Trials/NCT06641843
NCT06641843
Enrolling By Invitation
Not Applicable

Magnetic Resonance Myocardial Stress Perfusion: to Improve the Myocardial Evaluation in Pediatric Patients with Cardiovascular Disease

West China Second University Hospital1 site in 1 country240 target enrollmentSeptember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kawasaki Disease
Sponsor
West China Second University Hospital
Enrollment
240
Locations
1
Primary Endpoint
Major adverse cardiovscualr events
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

the goal of this observational study is to evaluate myocardial ischemia and myocardial microcirculation dysfunction in children with cardiovascular disease by myocardial stress perfusion imaging.

During their disease progress, participants will undergo myocardial stress perfusion, laboratory tests when hospitalization and follow-up, and the baseline data will be collected in the admission. all the above examination data will be analysed to identify early subclinical myocardial changes and evaluate the value of magnetic resonance myocardial stress perfusion in predicting prognosis.

Registry
clinicaltrials.gov
Start Date
September 1, 2024
End Date
September 30, 2034
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
West China Second University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ling-Yi Wen

Principal Investigator

West China Second University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients diagnosed with cardiovascular disease, including Kawasaki disease, anomalous origin of coronary artery, postoperative congenital heart disease.

Exclusion Criteria

  • Mental abnormalities or poor compliance ; heart, kidney and other important organs were seriously incomplete.
  • MRI examination contraindications ; gadolinium contrast agent contraindications ; claustrophobia.

Outcomes

Primary Outcomes

Major adverse cardiovscualr events

Time Frame: 10 years after the onset

Major adverse cardiovascular events including cardiac death, transient ischemic attack or stroke, myocardial infarction, arrhythmia, heart failure, severe valvular disease, percutaneous coronary intervention, coronary artery bypass graft, and other cardiovascular surgery.

Study Sites (1)

Loading locations...

Similar Trials